Tag: Meningioma risk

Meningiomas, the most common type of primary brain tumor in adults, are frequently hormone-sensitive and occur more often in women. While recent research has highlighted a concerning association between prolonged use of injectable medroxyprogesterone acetate (MPA) and an increased risk of meningioma, findings for the oral form differ significantly. This article addresses the crucial question: Does oral medroxyprogesterone cause meningioma? (Spoiler: The data says no).

In 2004, the FDA issued a black box warning regarding potential bone mineral density loss with long-term use of injectable medroxyprogesterone. This action raised significant questions about **is medroxyprogesterone safe for long-term use?** for contraception and other conditions.